NCT04187014View on ClinicalTrials.gov

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 6, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Blood Loss, Surgical
Interventions
DRUG

Aminocaproic Acid 1000Mg Tab

Oral administration of a total 6 g of aminocaproic acid to reduce blood loss

DRUG

Tranexamic acid tablets

Oral administration of 3.9 g of tranexamic acid to reduce blood loss

Trial Locations (1)

66460

Universidad Autonoma de Nuevo Leon, Monterrey

All Listed Sponsors
lead

Carlos A Acosta-Olivo

OTHER

NCT04187014 - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement | Biotech Hunter | Biotech Hunter